Literature DB >> 32826787

ASSOCIATION BETWEEN CHOROIDAL CHARACTERISTICS AND SYSTEMIC SEVERITY IN AMYLOIDOSIS.

Fukutaro Mano1,2, Angela Dispenzieri3, Shunji Kusaka2, Carlos Pavesio4, Hagar Khalid4, Pearse A Keane4, Jose S Pulido1,5,6.   

Abstract

PURPOSE: This study aimed to describe the choroidal features of ocular amyloidosis using multimodal imaging, to correlate these findings with systemic involvement, and to propose a choroidal grading system.
METHODS: Eleven patients with systemic amyloidosis were reviewed retrospectively. Each case was assigned a grade according to the severity of choroidal findings as determined by both enhanced depth imaging optical coherence tomography and indocyanine green angiography. The severity of systemic amyloidosis was then correlated with the choroidal involvement.
RESULTS: On indocyanine green angiography, all patients exhibited hyperfluorescent spots in the late stage and were classified according to preexisting criteria. On enhanced depth imaging optical coherence tomography, hyperreflective foci were seen in the choriocapillaris and Sattler's layer in Grade 1, partial loss of Sattler's layer was additionally seen in Grade 2, and a dense hyperreflective Haller's layer was seen in Grade 3. Choroidal grading scores were significantly correlated with the systemic severity score (P = 0.0014, Pearson's correlation coefficient; ρ = 0.83).
CONCLUSION: With ocular amyloidosis, evaluation of choroidal characteristics using multimodal imaging may serve as a biomarker for systemic involvement.

Entities:  

Mesh:

Year:  2021        PMID: 32826787     DOI: 10.1097/IAE.0000000000002961

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  3 in total

1.  Angiographic dark choroid in systemic non-hereditary amyloidosis.

Authors:  Konstantin V Astafurov; Andrew J Barkmeier
Journal:  Am J Ophthalmol Case Rep       Date:  2022-02-08

2.  Application of optical coherence tomography angiography to assess systemic severity in patients with hereditary transthyretin amyloidosis.

Authors:  Shinji Kakihara; Takao Hirano; Junya Kitahara; Yorishige Matsuda; Akira Imai; Teruyoshi Miyahara; Toshinori Murata
Journal:  PLoS One       Date:  2022-09-26       Impact factor: 3.752

Review 3.  Ocular Involvement in Hereditary Amyloidosis.

Authors:  Angelo Maria Minnella; Roberta Rissotto; Elena Antoniazzi; Marco Di Girolamo; Marco Luigetti; Martina Maceroni; Daniela Bacherini; Benedetto Falsini; Stanislao Rizzo; Laura Obici
Journal:  Genes (Basel)       Date:  2021-06-22       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.